Risk Breakdown
Financial Exposure
Governance
Double Materiality
Supply Chain
Material Risks
ESG Targets & Commitments
| Topic | Target / Metric | Status |
|---|---|---|
| Human Rights in Supply Chain | HR clauses in all contracts | Commitment |
AI Risk Summary
**Blue Jet Healthcare Limited – Financial Risk Summary** Blue Jet Healthcare faces critical compliance exposure under SEBI BRSR Core Expansion with a maximum compliance risk score of 10.0/10, carrying delisting and enforcement action risk for top-tier companies; estimated remediation costs of ₹2–6 crore represent 0.2–0.6% of revenue. Extended Producer Responsibility (EPR) liability represents the second-largest financial threat (6.5/10 exposure), though applicability remains unconfirmed—failure to clarify and implement EPR obligations could trigger unexpected levies and operational penalties under pharmaceutical waste management rules. The company's missing Scope 1 and 2 emissions data creates dual risk: inability to measure carbon liabilities under India's emerging carbon trading scheme (₹600–900/tonne benchmark) and non-compliance with BRSR P6 environmental disclosure mandates, which could trigger regulatory scrutiny and investor capital access constraints.
Source: Blue Jet Healthcare Limited BRSR Filing, FY -. Derived from the company's own public disclosures. Not investment advice or a regulatory determination.